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Some of the most challenging problems in the use of epidemiology for regulatory policy concern summarizing epidemiological and other kinds of
information to create a weight of evidence. Anotherfrequent issue is whether to embark on epidemiological study. There are also concerns that neg-
ative results never see the light of day. These and other meta-issues are worthy of funded evaluation by expert work groups. - Environ Health
Perspect 101(Suppl 4): 67-69 (1993).
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Risk Assessment Policy Needs Putting It All Together:
Go Beyond Research Needs Methodological ssues in
Weiahina aBodv of Evidence
So far we have discussed areas of exposure
analysis, study design, and data analysis in
which methodological improvements are
needed andworthy ofresearch support. For
the most part, this support will go to indi-
vidual researchers to help finance the time
spentdeveloping and testing newmethods.
In this paperwe discuss scientific activities,
such as the systematic and consistent summa-
rization ofa body ofevidence, the decision to
initiate more study, and the condusion that
enough isenough.
These are issues ofrisk assessment policy
and research strategy, and while not as value
laden as risk management (which we do not
address in this document), they are by
nature a matter ofscientific consensus. For
this reason, support for the formation of a
risk assessment policy often involves devel-
opment ofdraft documents by governmen-
tal and nongovernmental scientists and the
systematic review and development ofpro-
cedure by groups of researchers. We begin
by raising some ofthe issues ofa risk asssess-
ment policy and discuss in the last section
how this policy or related research needs
could be supported. To place these consid-
erations in context, we must remember that
most risk assessment must proceed with
only animal data. Therefore, the issues
raised here, though important, apply to a
small proportion ofregulatorydecisions.
Repeated strong epidemiological findings can
implicate a remediable environmental exposure
even without supporting animal toxicological
evidence oridenti:ng aresponsible agent. An
examplewould be thewell-known strong asso-
ciation between carcinoma ofthe nasal sinus
and cabinet making (1). Industrial hygienic
precautions can beinstituted even before abet-
ter understanding ofthe responsible mecha-
nism is darified. Here, epidemiology alone
suffices to drive regulation. Strong consistent
resultsrequirenoimgenuitytosummuarze.
More frequently, the human epidemiolog-
ical results are not distinguishable from the
null, or the dose-response slope is so low that
bias or confounding could plausibly account
fortheobservedassociation. Alternatively, the
results mayimplicate somehingin the general
environment that cannot be avoided by some
easy measure that could, like a cabinetmakers
dust mask, be applied without an understand-
ing ofthe responsible agent. In this case, usu-
ally other disciplines are needed to pinpoint
the offending agent and its means ofcontrol.
For all ofthese reasons, most environmental
policy is set after considering the integrated
information from clinical medicine, basic
physical and biological science, animal toxicol-
ogy, exposure analysis, andabodyofepidemi-
ological evidence. When all ofthis evidence
points toward the same conclusion, policy
decisions are simplified. Often, however, the
evidence isconflicting. Somestudies arecalled
positive, andothers aresaidtobenegative, that
is,indistnguishablefromthenull.
The terms positive and negative suggest
a solidity that is misleading. One school of
thought reserves these terms for statistically
significant associations and tends to view
any association that does not achieve the
presetpvalue to be as good as no association
atall. Anotherschool suggests that informa-
tion from all studies should be pooled and
the decision to believe the results should be
based on Bayesian approaches that consider
prior plausibility and the cost ofa false posi-
tive or a false negative result. This issue
becomes particularly difficult when, as is the
caseinthecurrentdebateaboutlow-frequency
electromagnetic fields (2), the body ofposi-
tive epidemiological evidence has very weak
biological plausibility. Intuitively it is clear
that a higher relative risk or a greater num-
ber ofconfirmatory studies are necessary for
such a situation than would be for an agent
that is similar to a previously studied agent
whose mechanism of action is well under-
stood. The acceptance oferionite as a car-
cinogenic mineral fiber comes to mind. The
documentation of two villages with a rate
ratio of9000 and one animal study demon-
strating carcinogenicitywas sufficient for the
International Agency for Research on Cancer
(IARC) (3) to list erionite as a carcinogen.
The biological plausibility weighed heavily
here. Methodological research into how one
uses epidemiological and other types ofinfor-
mation to updatepriorprobabilityassessments
practically and intelligibly for environmental
decisionmakersis, therefore, ofhighpriority.
Agents that act by nonthreshold mecha-
nisms, as is the case with many carcinogens,
could conceivably produce unacceptable
numbers ofdisease in the population when
there is widespread exposure. This could
happen even when the exposures are so low
thattheincreaseinrelativeriskisundetectable.
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Although epidemiological studies cannot rule
out effects ofsocietal concern in this situation,
suchnegativeornullstudiescansometimeshelp
assess whether humans have higher or lower
sensitvitytoanagentthanexpectedonthebasis
ofanimal bioassays. This is a special topic
withintheproblemofsummarizingevidence.
Another problem that often faces those
who are trying to weigh a body ofevidence
is that negative studies (not distinguishable
from the null) are thought to be less likely
to be published than positive studies.
Censoring may occur at the level of the
researcher or the journal. For example, a
researcher may suggest a positive associa-
tion between a disease outcome and a vari-
able that was not originally induded in the
main hypothesis. The researcher probably
would not report a surprising lack ofasso-
ciation under the same circumstances. An
author whose main hypothesis was not sup-
ported in a study may decide not to submit
an artide or may become discouraged after
receiving routine editorial criticisms. All of
this could skew the available evidence.
This problem has been discussed previously
(4 ). It is time to see ifthe phenomenon is
substantial and to evaluate which, if any,
potential remedies should be applied.
Contexts in which Follow-up
Environmental Epidemiologic
Studies are Recommended
The usual motivation for academically based
epidemiologic research is to pursue acredible
hypothesis in a setting that promises a high
likelihood ofproviding a persuasive answer
because the amount ofexposure, the size of
the study population, and the ability to con-
trol bias and confounding are all favorable.
Research priorities from funding agencies
thus give as much attention to feasibility as
to the potential importance of the project
being funded. Hypotheses often derive from
basic science considerations or from animal
or other epidemiological evidence. Public
agencies, on the other hand, are often
directed to carry out studies whose answer
would be ofgreatpolicy interest even though
the low biological credibility of the tested
hypothesis orthe conditions ofstudymilitate
against thelikelihood ofapersuasive result.
Frequently, one or a fewstudies initiated
in either way are not considered persuasive.
When current epidemiological information
is insufficient, one is faced with the problem
ofdeciding ifanyadditional epidemiological
study is likely to be helpful (for example,
where animal evidence suggests the possibil-
ity of an effect large enough to be ofsocial
concern but too small to be detected toxico-
logically or epidemiologically under usual
exposure scenarios). If epidemiology offers
hope for demonstrating an effect, how
strong must a collection of positive studies
be to implicate an agent or estimate its
potency in humans? How strong must a
collection of negative studies be to give a
clean bill of health to an agent that is
thought to act by a mechanism that should
display a threshold ofeffect? In regulatory
toxicology, no single study is ever consid-
ered definitive. Instead, a specified number
of statistically significant studies in several
species and laboratory settings is routinely
required. This policy is pursued regardless
ofconsiderations such as strength of effect,
prior plausibility, or the social costs offalse
positive or negative results. While this pro-
cedure would not be advocated for epidemi-
ology, it does remind us that no single study,
especially a screening study, is likely to be
definitive and that initiating an investigation
for scientific or public policy reasons usually
commits one to a sequence ofstudies until a
bodyofevidence has accumulated. The prin-
ciples thatguidetheinitiation and termination
ofthis commitmentneedelucidation.
When concerned segments ofthe public
demand a study in a particular setting, for
instance the Love Canal or large areas ofLos
Angeles where there is aerial application of
malathion for the Mediterranean fruit fly,
they often have a legitimate desire to partici-
pate in the design, conduct, and interpreta-
tion ofthe results. They often have unique
"shoe leather" experience as to routes of
exposure, hypotheses about effects that they
wish to be addressed, and susceptibility to
and concerns about potential conflicts of
interest in the analysis process. Often the
results (or media interpretation of the
results) from one such location can have
profound impact on nationalpolicy.
Several methodological research questions
arisefrom the involvement ofmembers ofthe
public. How well do various techniques of
involvement work, practically, for citizen sat-
isfaction, and with regard to avoiding bias in
study results? How does the presentation of
epidemiological results and the social setting
in which that presentation takes place influ-
ence the understanding and acceptance of
results? How can one safely assume that a
local community correctly registers and
remembers study results carried out on its
behalf, given that its perception ofthe results
influenceslocal andnationalpolicy?
Theavailabilityofmorbidityandmortality
databasesoffers bothopportunities anddilem-
mas. Academicepidemiology has traditionally
turned to available data bases to look for
unsuspected variations with regard to person,
place, and time as afirststep tounerthingthe
activity ofsome causal agent. This approach
was often useful in the early days ofinfectious
disease epidemiology-, and recently there have
been some successes in China, where sharp
regional variations in chronic disease rates (5)
have led to the discovery ofcausal agents of
indoor air pollution [female lung cancer in
southem China (6)] ordeficienciesorexcesses
in traceelements [selenium (7)].
Despite these isolated instances and the
usefulness ofthese data bases in occupational
and life-style epidemiology, it is striking how
difficultit is tofindexamples inmodem devel-
oped countries in which the routine surveil-
lance ofmorbidity and mortality for temporal
or spatial variations has led to the discovery of
newcausalfactorsinthephysicalenvironment.
These sources ofinformation have been more
useful for following the course and control of
diseaseofknown origin andfortestingspecific
hypotheses that arose from other considera-
tions. Despite this unpromising record, there
are politicians and scientists who have high
hopes forscreening studies based ontheanaly-
sis ofroutine data. This can be fruitful even
when there is no biologicallybasedhypothesis,
but the opportunity for chance associations
from multiple comparisons is great. In amore
hypothesis-testing mode, onecanexploreexist-
ing data to askwhether a single locality (or all
localities) containing some environmental haz-
ard has (or have) higher rates ofa particular
disease. The opportunities for chance associa-
tions after multiple comparisons also are great.
The availability ofsuch data also facilitates the
generic dustering study in which one asks ifa
disease dusters more than chance or demo-
graphicswouldsugge. Theanswerallowsthe
researcherto assessthehypothesisthatadisease
is spread from person to person or from a
point source. The traditional academic
hypothesis-generating strategies thus have
potential for initiating a wild-goose chase in
environmental epidemiology. There is a need
foradearrationaleforinitiatingsuchendeavors
while considering the subsequent commitment
itentails.
Methodological Research
Questions
We have raised some research and policy
issues that arise when summarizing epidemi-
ological evidence or deciding to initiate new
studies in service to the regulatory process.
Wewill brieflydiscuss them below.
How can funding agencies advance the
state ofknowledge and the quality ofpractices
in these several areas? As mentioned before,
sciencepolicyrequiresaconsensusprocessand,
therefore, requires the support ofresearchers
working as a group. Efficiency dictates that
some researchers be supported to prepare the
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groundwork or oversee and summarize the
consensus process while others are supported
to participate in it. Care should be given to
invitingparticipants with a range ofdisciplines
and backgrounds so that persons with various
kinds ofpractical experience are balanced by
individuals who are not grounded in the more
traditional ways ofdoing or thinking about
things. A variety of mechanisms could be
appropriate for the different areas dealt with
below. These indude supporting outside sci-
entists to work with government scientists to
develop draft guidelines or work out discus-
sions ofthe rationale for approaching a partic-
ular problem. They indude RFP support for
individuals, the intensive work group sessions
to resolve a problem procedure, or a work-
shop or conference to summarize a consen-
sus. While support for such activities can
be as costly as support for laboratory or
clinical research, the yield can be useful for
the regulatoryandscientificprocesses.
Epidemiological Evidence
Howshouldabodyofepidemiologicalevidence
be summarized for hazard identification and
dose-response purposes? How should biologi-
calbackgroundinformationbeincorporated?
These questions concern more than statis-
tical meta-analysis. There are somevery inter-
esting issues relating to the ability of the
human mindto integratelargebodies ofinfor-
mation and summarize them in consistent
ways. Prioropinions often influencethe inter-
pretation and weight ofevidence. This area
may benefit from an analysis ofexpert behav-
iorandartificial intelligence. Theissueofposi-
tiveandnegativestudiesarises. Itisinappropriate
to pass each study through a test ofstatistical
significance and contrast the number ofposi-
tiveandnegativestudies. Whataltematives are
there to the semantics ofthis terminology and
the practices that arise from them? To the
extent that the process becomes more explicit,
hidden biases will be less important and the
process will be less arbitrary and capricious for
regulatorypurposes.
The PriceofSampleInformation
When should epidemiological study be sup-
ported rather than laboratory or clinical
study, and how many studies of varying
kind and size are needed to determine that
a hazard exists at current doses or that a
hazard is unlikely at existing doses?
We cannot hope for a cut-and-dried pro-
cedure to make these determinations, but the
elements that should go into such decisions
need broader and more fundamental discus-
sion and understanding. We need to bring
together decision analysts, epidemiologists, sta-
tisticians, regulatory lawyers, and toxicologists
to studycase histories and to propose theoreti-
cally sound and practical approaches to decid-
ingwhen to startandhowmuch is enough. A
published discussion ofthe issues, similar to
the National Research Council's (NRC) risk
assessment/risk management report of 1983
(8), may reduce the frequencyoffalse positive
and negative epidemiological studies, inappro-
priate waiting for unneeded studies, and the
misuseofan inadequate numberofnegative or
positivestudies tomakedecisions.
Documenting andRemedying
NegativePublication Bias
Despite thoughtful discussions ofthe allega-
tion that negative studies are less likely to be
published, the extent ofthe problem and rea-
sons (ifany) for it have not been fully docu-
mented. Oncethis is betterunderstood, along
with the likely uses ofnegative results, alterna-
tiveapproaches shouldbeproposedandamar-
ket survey conducted to determine the
acceptability ofthe alternatives. A journal of
abstracts is one option, and a peer-reviewed
electronic data base with abstracts keyed into
electronically retrievable detailed documenta-
tion is another. The benefit ofunderstanding
and remedying this problem is that negative
studies, and reviewers' concerns about them,
would be available as societal decisions are
being made. However, an obvious danger is
that negative studies may be negative because
theyarepoorlyconceivedorpoorlyexecuted.
TheImplications ofInvolingthe
Public
What evidence daims that public concern or
involvement can improve or bias study results
or influence response rates? Once a study is
done, what is the prevalence ofknowledge
about its results, and what is the duration of
thatknowledge? What interventions influence
this? Here lies the borderland between epi-
demiology and evaluation research, similar to
research in antismokingorcontraception cam-
paigns, except thatsegments ofthepublic may
view effective efforts to disseminate epidemio-
logical research information as propaganda for
environmental inaction. The benefits ofabet-
ter understanding would be improved public
health practice and public decision making
based on evidence rather than misconception.
Acaveat must begiven here. Environmentally
cautious actions are often warranted even in
thefaceofnegativeepidemiological results that
are well disseminated and understood by the
public. It is nonethelesshelpful to bedear, for
future reference, as towhetherepidemiological
evidence influencedthedecision.
WhyEpidemiologyMustBeSkeptical
Theory can predict that a certain propor-
tion ofcomparisons will be statistically sig-
nificant or that a shared methodological
flaw can produce a false association in mul-
tiple studies. But both the scientific com-
munity and the general public are more
convinced by empirical demonstrations of
these theoretical predictions. For example,
in how many occupational studies is a vari-
able like month of birth associated with
disease? How many examples can we find
in which several studies seemed to impli-
cate an agent but subsequent studies failed
to confirm the initial findings? Case stud-
ies like these can help journalists, the pub-
lic, and decision makers to better understand
the importance ofa solid body ofevidence
for making good policy. e
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